China SXT Pharmaceuticals, Inc. (SXTC)
5.01
+4.17 (496.43%)
Inactive · Last trade price on Feb 25, 2025

China SXT Pharmaceuticals Revenue

In the fiscal year ending March 31, 2024, China SXT Pharmaceuticals had annual revenue of $1.93M, down -2.19%. China SXT Pharmaceuticals had revenue of $988.91K in the half year ending March 31, 2024, a decrease of -37.20%.

Revenue (ttm)
$1.93M
Revenue Growth
-2.19%
P/S Ratio
0.38
Revenue / Employee
$25,713
Employees
75
Market Cap
2.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241.93M-43.18K-2.19%
Mar 31, 20231.97M-630.60K-24.23%
Mar 31, 20222.60M-2.18M-45.53%
Mar 31, 20214.78M-384.70K-7.45%
Mar 31, 20205.16M-1.85M-26.38%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.